Sun, Huazheng
Li, Jian
Du, Changpu
Zhou, Kangmin
Wu, Zhenzhen
Deng, Jia
Chen, Guo
Liang, Ailing
Yang, Bing
Tang, Dongxin
Funding for this research was provided by:
National Natural Science Foundation of China (Grants 82260957, Grants82274610)
Guizhou Provincial Scientific and Technological Program (Grants Qian Ke He Ji Chu-ZK [2022] General 498, Qian Ke He Ji Chu-ZK [2022] General 487)
2024 National-Level College Student Innovation and Entrepreneurship Training Project (Project No. 2024106620598)
Research Center for Translational Engineering in the Prevention and Treatment of Tumors with Traditional Chinese Medicine and Ethnomedicine at Guizhou Universities (Document No. Qian Jiaojie [2023]037)
Article History
Received: 13 July 2025
Accepted: 9 September 2025
First Online: 13 October 2025
Declarations
:
: The authors declare no competing interests.
: The public data we used to validate our key genes were sourced from the TCGA, and HPA databases, as cited in our paper. This data was utilized solely for research purposes.This study did not involve prospective clinical decision-making. Any predictive models presented are for research purposes only and require independent validation before clinical application.